Canine Osteoarthritis: Welfare and Multimodal Pain Management

Osteoarthritis is the most common chronic pain condition in dogs, with welfare outcomes dramatically improved through multimodal management approaches.

Key Facts

Osteoarthritis affects around 20% of dogs over one year old
Clinical signs often appear only when 50% or more of joint cartilage is lost
Multimodal management includes NSAIDs, joint supplements, physiotherapy, and weight management
Monoclonal antibody therapies targeting nerve growth factor provide novel pain control
Hydrotherapy reduces joint loading while maintaining muscle mass in affected dogs

Welfare Considerations

Canine osteoarthritis causes chronic pain that profoundly reduces quality of life. Dogs often hide signs of chronic pain, leading owners to underestimate the welfare burden. Objective pain assessment using validated tools reveals widespread unrecognised suffering in the dog population. Multimodal management combining pain medication, weight management, exercise modification, and physical therapy provides substantially better welfare outcomes than NSAIDs alone. Novel biologic therapies offer hope for improved pain control in dogs responding poorly to traditional management.

What You Can Do

Monitor your dog for subtle signs of chronic pain including reluctance to exercise
Discuss multimodal arthritis management with your vet including novel biologic options
Maintain healthy body weight in your dog to reduce joint loading
Consider hydrotherapy or physiotherapy referral for arthritic dogs
Use validated quality of life assessment tools to monitor treatment effectiveness